Ligand Pharmaceuticals (LGND) Amortizatization of Intangibles (2015 - 2026)

Ligand Pharmaceuticals (LGND) has 12 years of Amortizatization of Intangibles data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 79.02% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 179.23% YoY), and the FY2025 full-year result was $5.0 million, up 272.5% from the prior year.
• Amortizatization of Intangibles eased to $1.5 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.0 million in Q4 2025 to a low of -$51000.0 in Q1 2022.
• A 5-year average of $534882.4 and a median of $377000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles plunged 82.93% in 2022 and soared 5285.71% in 2023, its largest moves.
• Tracing LGND's Amortizatization of Intangibles over 5 years: stood at $59000.0 in 2022, then jumped by 544.07% to $380000.0 in 2023, then jumped by 59.47% to $606000.0 in 2024, then soared by 232.51% to $2.0 million in 2025, then retreated by 25.46% to $1.5 million in 2026.
• Business Quant data shows LGND's Amortizatization of Intangibles at $1.5 million in Q1 2026, $2.0 million in Q4 2025, and $1.3 million in Q3 2025.